A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 22, Issue 9, Pages 1886-1894
Publisher
Oxford University Press (OUP)
Online
2013-01-23
DOI
10.1093/hmg/ddt019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Functional Copy-Number Variation in MAPKAPK2 Predicts Risk and Prognosis of Lung Cancer
- (2012) Bin Liu et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Germline copy number variations and cancer predisposition
- (2012) Ana Cristina Victorino Krepischi et al. Future Oncology
- Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population
- (2012) Jing Dong et al. NATURE GENETICS
- Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform
- (2011) Jeanette E Eckel-Passow et al. BMC BIOINFORMATICS
- Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk
- (2011) Liming Huang et al. CARCINOGENESIS
- A functional polymorphism at microRNA-629-binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population
- (2011) Lei Yang et al. CARCINOGENESIS
- p73 tumor suppressor protein: A close relative of p53 not only in structure but also in anti-cancer approach?
- (2011) Joanna Zawacka-Pankau et al. CELL CYCLE
- A gender-specific association of CNV at 6p21.3 with NPC susceptibility
- (2011) K.-P. Tse et al. HUMAN MOLECULAR GENETICS
- The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in southern and eastern chinese populations
- (2011) Jiachun Lu et al. HUMAN MUTATION
- Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma
- (2011) Lisa Cancemi et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms for Nonrecurrent Genomic Rearrangements Associated with CMT1A or HNPP: Rare CNVs as a Cause for Missing Heritability
- (2010) Feng Zhang et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis
- (2010) J. Gu et al. Cancer Prevention Research
- A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum
- (2010) K. M. Walsh et al. ENDOCRINE-RELATED CANCER
- WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis
- (2010) Adam J.W. Paige et al. EUROPEAN JOURNAL OF CANCER
- WWOXgene and gene product: tumor suppression through specific protein interactions
- (2010) Zaidoun Salah et al. Future Oncology
- Missing heritability and strategies for finding the underlying causes of complex disease
- (2010) Evan E. Eichler et al. NATURE REVIEWS GENETICS
- WWOX Gene Expression Abolishes Ovarian Cancer Tumorigenicity In vivo and Decreases Attachment to Fibronectin via Integrin 3
- (2009) C. Gourley et al. CANCER RESEARCH
- A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect
- (2009) Luca Agnelli et al. GENES CHROMOSOMES & CANCER
- Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis
- (2008) Iuliana Ionita-Laza et al. GENOMICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started